Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Clinical Protocols × Clear all

NCT03714555 2023-10-18

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

Phase 2 Terminated

1 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms